Achillion Pharmaceuticals, Inc. (ACHN) Posts Q3, Nine-Month Results; Shares Tumble
Shares of Achillion Pharmaceuticals (NASDAQ: ACHN) are sharply lower after the company reported its third quarter and nine-month financial results. Achillion posted a third-quarter net loss of $20.7 million or $0.15 per share, compared with net income of $26.3 million or $0.19 per share for the third quarter of 2015. For the nine months ended September 30, 2016, Achillion reported a net loss of $57.3 million, compared to a net loss of $22.0 million in the same period in 2015. The company also said it will present at the 58th Annual Meeting of the American Society of Hematology (ASH) in San…







